Prostate Cancer
Prediction of Resistance to 177Lu-PSMA Therapy by Assessment of Baseline Circulating Tumor DNA Biomarkers.
October 2, 2023
High dose rate brachytherapy for prostate cancer: A prospective toxicity evaluation of a one day schedule including two 13.5 Gy fractions.
October 1, 2023
Direct Patlak Reconstruction of [68Ga]Ga-PSMA PET for the Evaluation of Primary Prostate Cancer Prior Total Prostatectomy: Results of a Pilot Study.
September 29, 2023
T2-Weighted MRI Radiomic Features Predict Prostate Cancer Presence and Eventual Biochemical Recurrence.
September 29, 2023
Pretest PSA and Restaging PSMA PET/CT Predict Survival in Biochemically Recurrent Prostate Cancer.
September 29, 2023
MRI-Guided Radiation Therapy for Prostate Cancer: The Next Frontier in Ultrahypofractionation.
September 29, 2023
The utility of [18F]Fluciclovine PET/CT in Evaluating Nonmetastatic Castrate Resistant Prostate Cancer Patients (nmCRPCp): Diagnostic performance and Impact on Management.
September 28, 2023
Association Between Urologist Merit-based Incentive Payment System Performance and Quality of Prostate Cancer Care.
September 28, 2023
Prostate-specific membrane antigen radioguided surgery with negative histopathology: an in-depth analysis.
September 28, 2023
Precision intervention for prostate cancer: Re-evaluating who is at risk.
September 28, 2023
A MYC and RAS co-activation signature in localized prostate cancer drives bone metastasis and castration resistance.
September 28, 2023
Docetaxel radiosensitizes castration resistant prostate cancer by downregulating CAV-1.
September 27, 2023
Prognostic impact of serum testosterone in metastatic hormone-naive prostate cancer: a systematic review and meta-analysis.
September 27, 2023
Low-Value Prostate Cancer Screening Among Young Men With Private Insurance.
September 27, 2023